argenx SE | ARGX - Cash And Equivalent

Stock Price
616.00
Daily Change
-0.80 -0.13%
Monthly
-13.77%
Yearly
9.03%
Q1 Forecast
598.33

argenx SE reported $4.3B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AstraZeneca USD 8.14B 1.08B Sep/2025
Galapagos EUR 87.87M 23.41M Dec/2025
Genmab DKK 1.3B 323M Jun/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
UCB EUR 1.57B 1.14B Dec/2024